Zacks: Analysts Expect UnitedHealth Group Inc (UNH) Will Announce Earnings of $2.50 Per Share
Brokerages expect UnitedHealth Group Inc (NYSE:UNH) to report earnings per share of $2.50 for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for UnitedHealth Group’s earnings, with the highest EPS estimate coming in at $2.54 and the lowest estimate coming in at $2.46. UnitedHealth Group posted earnings of $2.11 per share in the same quarter last year, which indicates a positive year over year growth rate of 18.5%. The business is expected to issue its next quarterly earnings results before the market opens on Tuesday, January 16th.
On average, analysts expect that UnitedHealth Group will report full-year earnings of $9.99 per share for the current year, with EPS estimates ranging from $9.95 to $10.02. For the next year, analysts expect that the firm will post earnings of $11.11 per share, with EPS estimates ranging from $10.65 to $12.16. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow UnitedHealth Group.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.50 by $0.09. The firm had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the firm earned $2.11 EPS.
Shares of UnitedHealth Group (NYSE UNH) traded up $3.25 on Tuesday, reaching $228.64. 3,942,400 shares of the company traded hands, compared to its average volume of 2,822,722. The stock has a market cap of $225,820.00, a price-to-earnings ratio of 25.98, a P/E/G ratio of 1.54 and a beta of 0.66. UnitedHealth Group has a 12-month low of $156.09 and a 12-month high of $231.77. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.
In related news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction that occurred on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction that occurred on Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the sale, the chief executive officer now owns 195,314 shares in the company, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders have sold 34,630 shares of company stock worth $7,669,416 over the last 90 days. Insiders own 0.89% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the stock. Capital International Investors boosted its holdings in UnitedHealth Group by 399.3% in the third quarter. Capital International Investors now owns 4,132,602 shares of the healthcare conglomerate’s stock valued at $809,370,000 after purchasing an additional 3,304,902 shares in the last quarter. Jennison Associates LLC boosted its holdings in UnitedHealth Group by 146.0% in the third quarter. Jennison Associates LLC now owns 5,541,977 shares of the healthcare conglomerate’s stock valued at $1,085,396,000 after purchasing an additional 3,289,470 shares in the last quarter. Janus Henderson Group PLC boosted its holdings in UnitedHealth Group by 1,820.1% in the second quarter. Janus Henderson Group PLC now owns 2,388,641 shares of the healthcare conglomerate’s stock valued at $442,896,000 after purchasing an additional 2,264,242 shares in the last quarter. Vanguard Group Inc. boosted its holdings in UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock valued at $11,974,168,000 after purchasing an additional 1,588,516 shares in the last quarter. Finally, Parametric Portfolio Associates LLC boosted its holdings in UnitedHealth Group by 77.3% in the second quarter. Parametric Portfolio Associates LLC now owns 3,584,134 shares of the healthcare conglomerate’s stock valued at $664,570,000 after purchasing an additional 1,562,661 shares in the last quarter. Hedge funds and other institutional investors own 86.09% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Zacks: Analysts Expect UnitedHealth Group Inc (UNH) Will Announce Earnings of $2.50 Per Share” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.americanbankingnews.com/2018/01/16/zacks-analysts-expect-unitedhealth-group-inc-unh-will-announce-earnings-of-2-50-per-share.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.